ACHE and Alzheimer disease: In the present results, the multifaceted targets of hispolon and its analogs in free radical scavenging activities, anti-nitric oxide productions, inhibitions against AChE and Aβ1 − 42 aggregations might be new routes for AD treatments in developing daily ingestions of functional foods or as lead compounds for medical therapies.